Part 2 reimbursement-consent treatment refusal

Editorial approval scope: The team checked current source fidelity, scope boundaries, dates, arithmetic, reader usefulness, practical workflow, and general-information limitations.

Current rule checkpoint

Live 42 CFR 2.14(a) does not prohibit a Part 2 program from refusing treatment until a self-consenting minor authorizes a use or disclosure needed to obtain reimbursement. The same sentence warns that state or local law may prohibit refusal by requiring the program to furnish the service regardless of ability to pay. HHS's final-rule fact sheet confirms that regulated entities were required to comply with the 2024 amendments by February 16, 2026. eCFR displays Title 42 as current through August 20, 2026 and last amended August 13, 2026.

Part 2 and service duties answer different questions

Current 42 CFR 2.14 addresses what Part 2 itself prohibits and points to state or local ability-to-pay protections. Build a jurisdiction matrix for required services, emergency duties, financial assistance, payer contracts, notice, appeal, abandonment, and continuity.

The disclosure must truly be necessary for reimbursement

Identify payer or payer route, recipient, required information, billing event, consent need, alternative payment path, lesser information, confidential communications, and current source. Avoid treating a customary full release as a necessary condition.

Use an accountable hold process

Record the decision owner, legal source, clinical urgency, safety screening, family explanation, minor choice, access supports, financial counseling, deadline, escalation, alternative referral, continuity plan, and final disposition.

Treat the federal sentence as a boundary, not a refusal policy

First verify that applicable state law lets the minor acting alone apply for and obtain the specific SUD treatment. Then identify the exact reimbursement use or disclosure, why it is necessary, intended recipient, information, timing, and consent requested. A program preference for insurance billing is different from a payer requirement or genuine inability to obtain reimbursement without disclosure.

Separately research state and local service duties, emergency and stabilization obligations, nondiscrimination requirements, licensing and funding conditions, contract terms, charity-care rules, and professional standards. Part 2's statement that it does not prohibit refusal does not displace those obligations.

Use a reviewable pre-refusal process

Explain the proposed disclosure and concrete consequence in language the minor can understand. Offer time, privacy, interpreter or disability support, questions, a copy of the consent, and a route to decline. Review self-pay, sliding scale, financial assistance, alternative funding, confidential communications, delayed billing, or a clinically appropriate referral when available.

Before delaying, limiting, or refusing treatment, require designated operational, privacy, clinical, financial, and legal review. Document the service requested, urgency, minor's decision, reimbursement facts, applicable duty analysis, alternatives offered, reviewer, decision, communication, and follow-up.

Keep safety and continuity visible

Screen for withdrawal, overdose, self-harm, violence, abuse, neglect, medical instability, and other urgent risks. Follow emergency and protective procedures when their thresholds are met. When care is not provided, give accurate next steps and avoid abandonment, retaliation, pressure, or a misleading promise that another program will accept the minor.

Document why the decision is proportionate

A useful decision record distinguishes inability to bill, inability to collect, inability to verify coverage, and unwillingness to use an available alternative. It identifies the amount or service at issue, time available, clinical effect of delay, legal sources, comparable cases, exceptions considered, approval level, and scheduled reassessment. This makes inconsistent or punitive treatment easier to detect.

The minor and family, when lawfully involved, can ask whether the requested disclosure is truly necessary, what narrower information would suffice, which payment alternatives were reviewed, what service duty applies, who approved the decision, how urgent needs will be handled, and where to challenge or revisit the result. Provide contacts and deadlines in an accessible format.

Review aggregate refusal outcomes by age, service, payer, location, language, disability support, and stated reason. Patterns may reveal a broken billing rule or an inequitable barrier even when each file contains an approval.

Example

Nine treatment holds reach review. Six have verified reimbursement necessity, state-law analysis, safety review, notice, alternatives, owner, and disposition; three cite only an unpaid estimate. Readiness is 6 of 9 holds.

Treatment-refusal checklist

• confirm state-law treatment authority and define the necessary reimbursement disclosure;
• separate program preference from a documented payment requirement;
• research every state, local, emergency, funding, licensing, and contract duty;
• explain consequences and feasible alternatives accessibly;
• obtain cross-functional approval before delay or refusal; and
• screen urgent risk, support continuity, and document the complete decision.

This is a high-risk, jurisdiction-specific decision. Part 2 alone cannot establish that refusing treatment is lawful or clinically appropriate.